The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
She joins a team of experts at ON Partners, including partners Nina McMaster and Suzanne Zebedee, Ph.D., both recognized for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback